B
BioPlus Co Ltd
KOSDAQ:099430
BioPlus Co Ltd
KOSDAQ:099430
Price:
5 500
KRW
-0.54%
Market Closed
Market Cap:
₩339B
Balance Sheet
Balance Sheet Decomposition
BioPlus Co Ltd
BioPlus Co Ltd
Balance Sheet Decomposition is not available for
BioPlus Co Ltd
BioPlus Co Ltd
Balance Sheet
BioPlus Co Ltd
BioPlus Co Ltd
Currency: KRW
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
3 436
|
2 847
|
15 994
|
41 028
|
18 351
|
46 004
|
38 673
|
|
| Cash |
0
|
17
|
18
|
19
|
21
|
16
|
38
|
|
| Cash Equivalents |
3 436
|
2 830
|
15 976
|
41 009
|
18 331
|
45 988
|
38 635
|
|
| Short-Term Investments |
1 040
|
0
|
0
|
0
|
60 600
|
18 998
|
3 000
|
|
| Total Receivables |
1 893
|
4 115
|
4 719
|
8 360
|
18 133
|
23 240
|
21 203
|
|
| Accounts Receivables |
1 893
|
3 645
|
4 364
|
7 805
|
16 643
|
22 061
|
16 956
|
|
| Other Receivables |
0
|
471
|
355
|
555
|
1 490
|
1 179
|
4 247
|
|
| Inventory |
2 363
|
3 807
|
4 789
|
4 672
|
8 670
|
7 780
|
9 981
|
|
| Other Current Assets |
521
|
133
|
237
|
356
|
305
|
1 315
|
3 964
|
|
| Total Current Assets |
9 253
|
10 902
|
25 738
|
54 416
|
106 059
|
97 336
|
76 820
|
|
| PP&E Net |
1 308
|
6 964
|
7 408
|
22 013
|
27 873
|
56 478
|
150 240
|
|
| PP&E Gross |
0
|
6 964
|
7 408
|
22 013
|
27 873
|
56 478
|
150 240
|
|
| Accumulated Depreciation |
0
|
1 097
|
1 940
|
3 312
|
4 277
|
6 483
|
8 017
|
|
| Intangible Assets |
1 840
|
787
|
715
|
1 811
|
1 772
|
4 024
|
4 733
|
|
| Goodwill |
0
|
1 236
|
1 236
|
839
|
839
|
2 758
|
3 043
|
|
| Note Receivable |
305
|
30
|
30
|
1 343
|
32
|
1 414
|
164
|
|
| Long-Term Investments |
0
|
0
|
730
|
6 969
|
6 560
|
7 959
|
9 272
|
|
| Other Long-Term Assets |
576
|
1 078
|
2 078
|
1 070
|
3 383
|
2 836
|
20 026
|
|
| Other Assets |
0
|
1 236
|
1 236
|
839
|
839
|
2 758
|
3 043
|
|
| Total Assets |
13 282
N/A
|
20 997
+58%
|
37 935
+81%
|
88 462
+133%
|
146 518
+66%
|
172 807
+18%
|
264 298
+53%
|
|
| Liabilities | ||||||||
| Accounts Payable |
395
|
368
|
775
|
994
|
1 152
|
606
|
1 010
|
|
| Accrued Liabilities |
0
|
299
|
348
|
372
|
821
|
919
|
1 322
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
2 006
|
|
| Current Portion of Long-Term Debt |
0
|
97
|
3 866
|
1 812
|
564
|
494
|
55 561
|
|
| Other Current Liabilities |
987
|
2 340
|
4 344
|
4 321
|
6 940
|
8 946
|
52 429
|
|
| Total Current Liabilities |
1 382
|
3 105
|
9 333
|
7 499
|
9 477
|
10 964
|
112 328
|
|
| Long-Term Debt |
4 487
|
46
|
38
|
369
|
6 205
|
8 766
|
2 746
|
|
| Minority Interest |
0
|
0
|
0
|
1 826
|
1 695
|
10 245
|
14 253
|
|
| Other Liabilities |
42
|
0
|
44
|
68
|
15 876
|
15 015
|
1 484
|
|
| Total Liabilities |
5 911
N/A
|
3 151
-47%
|
9 415
+199%
|
9 762
+4%
|
33 253
+241%
|
44 990
+35%
|
130 811
+191%
|
|
| Equity | ||||||||
| Common Stock |
2 916
|
3 120
|
3 120
|
7 182
|
28 965
|
28 965
|
29 149
|
|
| Retained Earnings |
170
|
5 759
|
15 334
|
26 217
|
47 354
|
69 633
|
79 587
|
|
| Additional Paid In Capital |
3 633
|
8 071
|
8 071
|
53 484
|
34 237
|
32 187
|
34 090
|
|
| Treasury Stock |
0
|
0
|
0
|
8 793
|
0
|
4 990
|
9 980
|
|
| Other Equity |
652
|
896
|
1 995
|
610
|
2 709
|
2 022
|
642
|
|
| Total Equity |
7 371
N/A
|
17 846
+142%
|
28 520
+60%
|
78 699
+176%
|
113 265
+44%
|
127 817
+13%
|
133 487
+4%
|
|
| Total Liabilities & Equity |
13 282
N/A
|
20 997
+58%
|
37 935
+81%
|
88 462
+133%
|
146 518
+66%
|
172 807
+18%
|
264 298
+53%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
56
|
56
|
56
|
56
|
58
|
57
|
57
|
|
Switch to:
Switch to:
See Also
Discover More
